Catrin Plumpton

8PUBLICATIONS
63CO-AUTHORS
Epidemiological modellingCancer geneticsPharmacogenomicsEconometric and statistical methodsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 31, 2026
Cost-effectiveness of screening for developmental dysplasia of the hip in children born in England and Wales.

|May 22, 2026
Cost-effectiveness of DPYD genotyping prior to fluoropyrimidine-based treatment for colorectal cancer in Wales.

|Dec 09, 2025
Health economic considerations for pharmacogenomic services in the United Kingdom: The Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics.

Dyfrig A Hughes, Henry Fong, Grace Hampson

|Apr 03, 2022
Linear mixed models to handle missing at random data in trial-based economic evaluations.

Andrea Gabrio, Catrin Plumpton, Sube Banerjee

|Feb 21, 2022
Supporting People With Type 2 Diabetes in the Effective Use of Their Medicine Through Mobile Health Technology Integrated With Clinical Care to Reduce Cardiovascular Risk: Protocol for an Effectiveness and Cost-effectiveness Randomized Controlled Trial.

Andrew Farmer, Louise Jones, Nikki Newhouse

|Dec 21, 2021
Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.

Anthony G Marson, Girvan Burnside, Richard Appleton

Pageof 2

Frequent Collaborators

6 joint publications

Dyfrig Hughes

2 joint publications

Paula R Williamson

1 joint publications

Anthony G Marson

1 joint publications

Girvan Burnside